-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Inhibikase Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2020 to Q3 2022.
- Inhibikase Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
- Inhibikase Therapeutics, Inc. annual Interest Expense for 2021 was $19.9K, a 32.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)